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Head & Neck Cancer (HNC) is one of the most common malignancies worldwide and among oral neoplasias about
90-92% are squamous cell carcinomas (OSCC). Alcohol and tobacco consumption have been recognized as the
main risk factors for development of OSCC. However, 10 to 20% of patients suffering from OSCC have no history of
use of these substances. Clinico-pathological evidence suggests that we are dealing with virally-induced cancers,
and that HPV should not be a relevant candidate. A systematic search of HPV in OSCC has no real relevance in
current clinical practice even although it is still relevant in organized research protocols. Further studies are
ongoing, with the aim of identifying other infectious agents, including viruses, in OSCC.View point
The search for an infectious cause of human cancers
remains a matter of great interest in medicine. The dis-
covery of a viral agent in a given tumor may have crucial
implications not only for diagnosis and better under-
standing of the tumor’s physiopathology, but also on its
prevention and/or treatment. This has been well illu-
strated in the link between cervical carcinoma and some
high-risk types of human papillomavirus (HPV), and for
liver cancer and hepatitis B/C infection. However, it is
probable that other cancers have infectious origins that
remain to be identified [1].
Head & Neck Cancer (HNC) is one of the most com-
mon malignancies worldwide, and is a high priority for
public health authorities. Among oral neoplasias, about
90-92% are squamous cell carcinomas (OSCC), develop-
ing from the mucosa, with the remaining 8-10% being
predominantly made up of lymphomas, sarcomas, and
salivary gland tumors. For many years, alcohol and
tobacco consumption have been recognized as the main
risk factors for the development of OSCC. However, 10
to 20% of patients suffering from OSCC have no history
of use of these substances. In this comment, we ask if,
based on current available data, it is clinically relevant to* Correspondence: chloe.bertolus@psl.aphp.fr
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The debate will be opened on the need to search for
other infectious agents in OSCC.
Different viruses have been looked for in HNCs. Most
of the studies, probably because of a certain analogy and
similarity to the situation found in cervical carcinoma,
have focused mainly on papillomaviruses, especially the
high risk ones. Human papillomavirus has been strongly
associated with oropharyngeal squamous cell carcinoma
(OPSCC). However, the prevalence of HPV infection in
OSCC is quite heterogeneous, varying from 17% to 85%
[2,3]. Anatomically, the oral cavity includes the inner
mucosal lips, the mucosal cheeks and vestibule, the mo-
bile part of the tongue, the gums, the floor of the mouth,
the intermaxillary region, and the hard and soft palate,
but excludes the oropharynx (i.e., the tonsils, the base of
the tongue, and the oropharyngeal walls). Strictly speaking,
the base of the tongue and the palatine tonsils are part of
the anterior and lateral wall of the oropharynx [4], and
belong to Waldeyer’s ring. Moreover, the histological char-
acteristics of the mucosa lining the oral cavity and the oro-
pharynx are quite different and constitute two distinct
entities. However, in many studies concerning HPV preva-
lence in HNCs, the base of the tongue and the palatine
tonsils have been considered part of the oral cavity, leading
to misinterpretation of the results [5,6]. The implication of
HPV in the development of OSCC, even if still a matter ofarticle distributed under the terms of the Creative Commons Attribution License
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because of the anatomical confusion described above [3].
As higher radiosensitivity has been reported for tonsil
HPV-SCC [7], this confusion can have implications on pa-
tient care. These therapeutic results cannot be extrapolated
to the oral cavity.
Besides alcohol and tobacco consumption, considered
as the historical and still major etiological factors for
OSCC, it is fair to hypothesize that infectious agents (and
mainly viruses) could be associated and/or causally linked
with a subset of OSCC. This hypothesis stems from the
fact that OSCC in non-smoker non-drinkers is more fre-
quently reported in an older population than alcohol-
tobacco-related cancer [8]. This is similar to the situation
with classic Kaposi sarcoma, non-HIV-associated primary
effusion lymphoma (both associated with KSHV/HHV-8)
and Merkel cell carcinoma being causally linked with the
recently discovered new human polyomavirus. Among the
possible infectious agents associated with OSCC, HPV is
an unlikely candidate, as HPV-associated cancer is most
frequently located in the oropharynx of young men [7].
Other clinico-pathological evidence suggests that we are
indeed dealing with virally-induced cancers. Some histo-
logical studies have shown that HPV-related OPSCCs
are non-keratinizing tumors, whereas non-HPV-related
OPSCCs are keratinizing [9]. This correlation between viral
infection and poor histological differentiation is not ex-
clusive to HPV: it is also found in other virally-induced
tumors. In nasopharyngeal carcinoma, for example, the
keratinizing form could be less associated with Epstein-
Barr virus [10]. In addition, an epidemiological study
has demonstrated significant trends towards decreased dif-
ferentiation in oral cavity tumors over the past 30 years
[11]. Such an increase of undifferentiated cancers, which
are thought to be “more virus-associated” [12], suggests
that new or unknown infectious agents could be
involved in OSCC in non-smoking, non-drinking patients.
Altogether, these results suggest that, if not due to HPV
involvement, the decreased differentiation of OSCC could
be attributable to another viral agent. Some studies have
been performed to look for other viruses as etiological
causes, but without real success [13-15].
In conclusion, recent epidemiological data tend to in-
dicate that the low diagnosis of HPV in OSCC is linked
with an actual low prevalence, independent of technical
and anatomical biases. Given our current knowledge, a
systematic search for HPV in OSCC is therefore a waste
of health service resources, and is only relevant in the
research environment, such as in organized research
protocols. However, further studies continue to search
for other infectious agents, including viruses, in OSCC.Competing interests
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